(Q40568827)

English

Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).

scientific article published on August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

7

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

object named as

Andrew D Blann

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Dirk C Felmeden

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Charles G C Spencer

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Natali A Y Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Funmi M Belgore

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

D Gareth Beevers

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

400-405

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

A general cardiovascular risk profile: The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Close relation of endothelial function in the human coronary and peripheral circulations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Impaired endothelial function with essential hypertension assessed by ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Angiogenesis: basic pathophysiology and implications for disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Angiogenesis and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900657-X

7 January 2021

Identifiers

10.1016/S0002-9149(03)00657-X

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40568827&oldid=1498544810"